These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22548337)

  • 1. Design, synthesis and multidrug resistance reversal activity evaluation of 8-oxocoptisine derivatives.
    Wu JB; Lei F; Cui XJ; He Y; Hai L; Zhang J; Wu Y
    Med Chem; 2012 Jul; 8(4):742-8. PubMed ID: 22548337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O
    Li Q; Zou P; Sun J; Chen L
    Eur J Med Chem; 2018 Jan; 143():732-744. PubMed ID: 29220794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
    Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
    Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis and structure-activity relationship of cycloberberine as anti-cancer agent].
    Bi CW; Zhang CX; Li YB; Zhao WL; Shao RG; Mei L; Song DQ
    Yao Xue Xue Bao; 2013 Dec; 48(12):1800-6. PubMed ID: 24689237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.
    Dei S; Coronnello M; Bartolucci G; Manetti D; Romanelli MN; Udomtanakunchai C; Salerno M; Teodori E
    Eur J Med Chem; 2018 Mar; 147():7-20. PubMed ID: 29421572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein.
    Kim MK; Kim Y; Choo H; Chong Y
    Bioorg Med Chem; 2017 Feb; 25(3):1219-1226. PubMed ID: 28043777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery to solve multidrug resistance: Design, synthesis, and biological evaluation of novel agents.
    Qiu Q; Shi W; Zhao S; Zhu Y; Ding Z; Zhou S; Kairuki M; Huang W; Qian H
    Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900127. PubMed ID: 31441108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20(S)-Protopanaxadiol (PPD) analogues chemosensitize multidrug-resistant cancer cells to clinical anticancer drugs.
    Liu J; Wang X; Liu P; Deng R; Lei M; Chen W; Hu L
    Bioorg Med Chem; 2013 Jul; 21(14):4279-87. PubMed ID: 23683834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structure-activity relationship and biological activity of acridine derivatives as potent MDR-reversing agents.
    Wang J; Luo T; Li S; Zhhang Y; Wang C; Zhao J
    Curr Med Chem; 2013; 20(32):4070-9. PubMed ID: 23895691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer.
    Li Y; Zhang HB; Huang WL; Li YM
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3652-5. PubMed ID: 18502125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and anticancer activity of novel berberine derivatives prepared via CuAAC "click" chemistry as potential anticancer agents.
    Jin X; Yan TH; Yan L; Li Q; Wang RL; Hu ZL; Jiang YY; Sun QY; Cao YB
    Drug Des Devel Ther; 2014; 8():1047-59. PubMed ID: 25120353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4,5-Di-substituted benzyl-imidazol-2-substituted amines as the structure template for the design and synthesis of reversal agents against P-gp-mediated multidrug resistance breast cancer cells.
    Zhang N; Zhang Z; Wong IL; Wan S; Chow LM; Jiang T
    Eur J Med Chem; 2014 Aug; 83():74-83. PubMed ID: 24952376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of hederagenin derivatives with improved aqueous solubility and tumor resistance reversal activity.
    Wang B; Liu S; Huang W; Ma M; Chen X; Zeng W; Liang K; Wang H; Bi Y; Li X
    Eur J Med Chem; 2021 Feb; 211():113107. PubMed ID: 33360797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
    Gao A; Wang X; Xiang W; Liang H; Gao J; Yan Y
    J Pharm Pharmacol; 2010 Mar; 62(3):393-9. PubMed ID: 20487225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory effect of kokusaginine on the growth of human breast cancer cells and MDR-resistant cells is mediated by the inhibition of tubulin assembly.
    Chen H; Li S; Wang S; Li W; Bao N; Ai W
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2490-2492. PubMed ID: 29903663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntheses and Structure-Activity Relationships in Growth Inhibition Activity against Human Cancer Cell Lines of 12 Substituted Berberine Derivatives.
    Wang B; Deng AJ; Li ZH; Wang N; Qin HL
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32325679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversal of multidrug resistance of tumor cells by FG020327 and its mechanism].
    Chen LM; Li YF; Zhang X; Yan SL; Liang YJ; Fu LW
    Ai Zheng; 2005 Feb; 24(2):189-93. PubMed ID: 15694031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
    Gao M; Xu Y; Qiu L
    J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.